Clinical trial · Interventional
Shear Wave Elastography of Prostate Cancer
NCT02425163CI-TRIAL-00017623ElaProCcompletedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Evaluation of significant Shear Wave Elastography Parameters for Prostate Biopsy and Prostate Cancer detection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Transrectal random biopsy of the prostate | Procedure | — | UNRESOLVED |
| Transrectal shear wave elastography of the prostate | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- ACTIVE_COMPARATOR
- label
- suspicious for Prostate Cancer
- description
- PSA \>4ng/ml or PSA-Velocity \>0.75ng/ml/a or suspicious rectal examination or Status after external beam therapy of the prostate in prostate cancer. Patients who are able for transrectal ultrasound examination. Transrectal shear wave elastography of the prostate for Transrectal random biopsy of the prostate.
- interventionNames
- Device: Transrectal shear wave elastography of the prostate
- Procedure: Transrectal random biopsy of the prostate
Primary outcomes (1)
- measure
- Shear wave elastography
- timeFrame
- 12 Months
- description
- transrectal shear wave elastography with detection of prostate tissue pressure \[kilo-Pascal\] in correspondence to biopsy areas
Secondary outcomes (4)
- measure
Eligibility
Eligibility (as posted)
Show eligibility criteria text
Inclusion Criteria: * Suspicious for prostate cancer with no pretreatment and Prostata specific Antigen (PSA) \>4ng/ml or PSA velocity \> 0.75 ng/ml per year or suspicious transrectal digital examination * Status after external beam radiotherapy of the prostate in localized prostate cancer and suspicious for local prostate cancer recurrence Exclusion Criteria: * None.
References
Publications (1)
- RESULTCorreas JM, Tissier AM, Khairoune A, Vassiliu V, Mejean A, Helenon O, Memo R, Barr RG. Prostate cancer: diagnostic performance of real-time shear-wave elastography. Radiology. 2015 Apr;275(1):280-9. doi: 10.1148/radiol.14140567. Epub 2014 Nov 19. PMID 25599156